Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

AXIS Capital Well Poised For Growth On Strategic Initiatives

Published 05/17/2016, 10:21 PM
Updated 07/09/2023, 06:31 AM

On May 17, we issued an updated research report on AXIS Capital Holdings Limited (NYSE:AXS) .

In the first quarter of 2016, the property and casualty insurer delivered operating earnings that beat the Zacks Consensus Estimate on higher premiums and a net favorable prior-year reserve development. However, revenues decreased. Underwriting results too were weak. Going by the surprise trend, the company delivered positive surprises in two of the last four quarters.

AXIS Capital remains focused on strengthening its Specialty Insurance, Reinsurance, as well as Accident and Health businesses. Also, the insurer always undertakes strategic initiatives that would help it to grow. The company already started underwriting operations in China that will concentrate on the treaty reinsurance business in Lloyd's China. Recently, the insurer’s subsidiary AXIS Healthcare forayed into the nursing home professional liability market. The company has also been expanding capabilities for AXIS Ventures, its third-party capital vehicle.

All these initiatives point to its strategic business plan that would help it to write more business. The company had $80 million in new business in the first quarter of 2016.

Backed byits operational strength, the company maintains its focus on effective capital deployment that also includes shareholder-friendly moves like dividend hike and share buybacks. In the final quarter of 2015,the company declared a 21% hike in its quarterly dividend and increased its share repurchase authorization to $750 million. The company presently has $625 million authorization remaining under the common shares repurchase program.

However, exposure to catastrophe losses and competition, escalating expenses and dependence on a limited number of brokers for revenues remain as headwinds. Also, a weak interest rate environment and a volatile equity market continue to weigh on investment results.

The Zacks Consensus Estimate is currently pegged at $4.08 per share for 2016 and $4.53 for 2017, translating to a year-over-year increase of 1.6% and 10.9% respectively.

Currently, the insurer carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the same space are Alleghany Corporation (NYSE:Y) , Cincinnati Financial Corp. (NASDAQ:CINF) and Markel Corp. (NYSE:MKL) . Each of these stocks sports a Zacks Rank #1 (Strong Buy).

CINCINNATI FINL (CINF): Free Stock Analysis Report

AXIS CAP HLDGS (AXS): Free Stock Analysis Report

MARKEL CORP (MKL): Free Stock Analysis Report

ALLEGHANY CORP (Y): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.